1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow LB100: new trials by email Literature Review of LB100 trials Research Report on LB100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas LB-100 plus Doxorrubicin, Doxorubicin - Advanced Soft-tissue Sarcoma | Phase 1 / Phase 2 | Active not recruiting | Grupo Espanol de Investigacion en Sarcomas | 152 | 2023-05-29 | 2025-03-21 |
Grupo Espanol de Investigacion en Sarcomas (1)
Spain (1)